Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.
  • الفعاليات
  • الأخبار
  • الرؤى
  • الحساب
Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

News

Categories

  • الأحدث
  • أشباه الموصلات
  • الأمن السيبراني
  • التكنولوجيا المالية
  • الدفاع
  • الذكاء الاصطناعي والتقنية
  • الرعاية الصحية
  • الروبوتات
  • الزراعة
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الطاقة والتنقل
  • سلسلة الإمداد

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • الأحدث
  • الذكاء الاصطناعي والتقنية
  • الأمن السيبراني
  • أشباه الموصلات
  • الروبوتات
  • التكنولوجيا المالية
  • الطاقة والتنقل
  • الدفاع
  • الرعاية الصحية
  • سلسلة الإمداد
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الزراعة

الأخبار

الرعاية الصحية

أحدث أخبار الرعاية الصحية والإعلانات والتحليلات من المؤتمرات والمعارض والقمم التي تشكّل القطاع.

الأحدث في القسم

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer (opens original source in a new tab)
STAT News

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.

(opens original source in a new tab)
Jason Mast·10 August 2026
STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed (opens original source in a new tab)
STAT News

STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.

(opens original source in a new tab)
Brian Yang·10 August 2026
STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients (opens original source in a new tab)
STAT News

STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient groups.

(opens original source in a new tab)
Ed Silverman·10 August 2026
Opinion: Fauci doesn’t have the answers on Covid’s origins. China does (opens original source in a new tab)
STAT News

Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

“To blame Fauci for not solving the origin of Covid-19 makes as much sense as blaming a detective in Washington, D.C., for not solving a murder in Wuhan,” writes David…

(opens original source in a new tab)
David J. Hunter·7 August 2026
STAT+: Up and down the ladder: The latest comings and goings (opens original source in a new tab)
STAT News

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

(opens original source in a new tab)
Ed Silverman·7 August 2026
STAT+: NIH plans to block international researchers on visas from accessing key funding avenue (opens original source in a new tab)
STAT News

STAT+: NIH plans to block international researchers on visas from accessing key funding avenue

The NIH plans to close the door on one of the few pathways available to international students on visas to forge a career in biomedical research in the U.S.

(opens original source in a new tab)
Anil Oza·7 August 2026
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more

Eli Lilly and Novo Nordisk convinced a federal judge to toss an antitrust lawsuit by a compound pharmacy

(opens original source in a new tab)
Ed Silverman·7 August 2026
Is the biotech capital of the world moving? (opens original source in a new tab)
STAT News

Is the biotech capital of the world moving?

Replimune finally wins FDA approval, the role of tau in Alzheimer's, and more biotech news from The Readout

(opens original source in a new tab)
Meghana Keshavan·7 August 2026
A third clinic settles with DOJ over trans care (opens original source in a new tab)
STAT News

A third clinic settles with DOJ over trans care

Anthony Fauci held in contempt, crackdowns on the organ donor network, and more health news from Morning Rounds

(opens original source in a new tab)
O. Rose Broderick·7 August 2026
STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California? (opens original source in a new tab)
STAT News

STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?

Boston, with its rising costs, high taxes, and business climate, is losing ground to rivals across the country, sometimes even in biotech.

(opens original source in a new tab)
Emma Platoff — Boston Globe·7 August 2026
Opinion: AI won’t enhance physician autonomy. It will further diminish it (opens original source in a new tab)
STAT News

Opinion: AI won’t enhance physician autonomy. It will further diminish it

“AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances Mei Hardin.

(opens original source in a new tab)
Frances Mei Hardin·7 August 2026
Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack (opens original source in a new tab)
STAT News

Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack

“It was briefly more dangerous to sit at a desk in Atlanta than to chase a hemorrhagic fever in the field,” writes Daniel Jernigan.

(opens original source in a new tab)
Daniel Jernigan·7 August 2026

الأكثر قراءة

  1. 01

    STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

  2. 02

    STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

  3. 03

    STAT+: A shortage of two Sanofi medicines for Pompe disease rattles patients

  4. 04

    Opinion: Fauci doesn’t have the answers on Covid’s origins. China does

  5. 05

    STAT+: Up and down the ladder: The latest comings and goings

Prev
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
Next
  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.

أسبوع فعاليات الصناعة، يُوصَّل كل جمعة.

بريد إلكتروني قصير واحد. أبرز القصص من المعارض التجارية والمؤتمرات والقمم التي تشكّل الأعمال حول العالم. بلا حشو، بلا بريد عشوائي، إلغاء الاشتراك في أي وقت.